Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
Pharmaceutical Investing Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment
Q Biomed Joins With Oklahoma Medical Research Foundation And Rajiv Gandhi Centre For Biotechnology To Develop Liver Cancer Chemotherapeutic
Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics in Metabolic Syndrome
Novartis LEE011 (ribociclib) Plus Letrozole Analyses Show Superior PFS in First-Line HR+/HER2- Advanced Breast Cancer
FenoLogica Biosciences Signs Licensing and Collaboration Agreement With the Pacific Northwest Research Institute
